pharmaphorum

JANUARY 20, 2022

Within this context, it goes without saying that Covid-19 has led to a big push towards digital healthcare solutions. HCPs also felt it was helpful to have more time to reassure and empathise with patients, with less time-pressure and more relaxed consultations. • Read the full article in pharmaphorum’s Deep Dive digital magazine.

98

98

pharmaphorum

OCTOBER 27, 2022

Read Deep Dive: Patients and Partnerships 2022 in full. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

NOVEMBER 24, 2020

“Every company has two choices: either they’ve got to lead change, and define a new normal, or see what others do and then play catch up forever.”. • Read the full article in pharmaphorum’s Deep Dive digital magazine. The post Thriving in COVID-19 with flexible marketing strategies appeared first on.

Communication 118

Communication 118

pharmaphorum

NOVEMBER 25, 2020

Former chief digital officer for the NHS, Juliet Bauer, is now applying her experience to the private sector through video consultation firm Livi. She shares her thoughts on how well the NHS is integrating digital health and what the public and private sectors can do to further boost adoption.

Hospitals 82

Hospitals 82

pharmaphorum

OCTOBER 1, 2021

Post-COVID evolution of pharma-doctor digital interactions. M3’s Tim Russell and Maxim Polyakov, together with Digital Futureway’s Heather Hancock, discuss new research on how doctor engagement has been altered by COVID-19. Refining pharma’s digital collaborations with HCPs. Subscribe to future issues of Deep Dive.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

NOVEMBER 6, 2020

Ahead of Frontiers Health 2020, steering committee members Roberto Ascione and Paul Tunnah from Healthware give us their thoughts on the trends driving the bright future of digital health. Much of this is, of course, down to COVID-19 – but it’s clear that digital health was already on the up and up long before the pandemic hit.

87

87

pharmaphorum

OCTOBER 15, 2021

Digital Health veteran Eugene Borukhovich has joined Healthware Group as senior advisor to its Media and Community business unit, which aims to foster dialogue and connections among the digital health community. The post Healthware Group appoints Eugene Borukhovich as senior advisor appeared first on.

Pharmaceutical Companies 124

Pharmaceutical Companies Pharmaceutical Companies 124

pharmaphorum

JANUARY 18, 2022

People with cancer and their caregivers have long been active participants in discussions of how they are treated, but in the current digital information age, it is becoming more common for patients to self-advocate for the latest advancements in therapy. The post Targeted agents and immunotherapies appeared first on.

98

98

pharmaphorum

SEPTEMBER 17, 2020

COVID-19 might have forced pharma to finally fully embrace digital communications, but that doesn’t mean the industry is good at using these platforms yet. In this issue we hear from a variety of KOLs who are leading pharma comms into a new, digital era to get their views on how pharma can best adapt for the post-COVID world.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

FEBRUARY 8, 2022

Covid-19 has lit a fire under the medical industry, driving them to re-evaluate and incorporate digital engagement models. Digital health has undergone a dramatic transformation over the past few years. Digital health has undergone a dramatic transformation over the past few years.

71

71

pharmaphorum

SEPTEMBER 22, 2022

Cut off from tried and tested methods of engaging with stakeholders, digital, and virtual solutions were thrust into the limelight as the industry proactively accelerated the adoption of technology across all levels of healthcare. The missing pieces of the digital therapeutics puzzle. Subscribe to future issues of Deep Dive.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 14, 2020

As this issue’s title suggests, patient centricity is about more than just talking points and marketing strategies – it requires companies to truly listen to, engage with and partner with the patients they serve, and in putting this month’s Deep Dive together it’s been great to see that so many pharma firms are now taking this to heart.

Pharmaceutical Companies 75

Pharmaceutical Companies Pharmaceutical Companies FDA 75

pharmaphorum

MAY 6, 2022

Closing the digital expectation gap in pharma. To compete in the digital world, pharma needs to catch up to other industries by creating seamless online experiences, says Takeda’s Jan Deman. Read Deep Dive: Market Access in full. Subscribe to future issues of Deep Dive.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JUNE 30, 2021

Read on for a look at highlights from ASCO, new approaches to clinical trials, and the transformative impact of digital in oncology. Plus we have a special focus on digital health startups and how digital companies are changing healthcare. . Digital tools key to immuno-oncology’s future: report.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

pharmaphorum

NOVEMBER 30, 2020

We speak to finalists from the Greater Manchester Future of Health accelerator to find out how digital start-ups can overcome the challenges small companies face in bringing their technologies into the NHS. The post Navigating the NHS as a digital start-up appeared first on. Adoption of new tech is still a real challenge.”.

71

71

pharmaphorum

FEBRUARY 24, 2022

Read on to find out using digital twins of clinical experiments could help drive progress in virtual biological models, why venture capitalists fell in love with pharma R&D in 2021, and why amplifying patient voices is vital in the rare disease space. Seeing double: the rise of digital twins in life sciences.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

pharmaphorum

JULY 7, 2022

Read Deep Dive: Oncology in full. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Subscribe to future issues of Deep Dive.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

FEBRUARY 15, 2022

Digital health and technologies offer a wealth of opportunities, but digital needs to become part of a company’s DNA to achieve transformation. Digital transformation has long been heralded the future of health. The internal overhaul is often the missing piece in digital calibration.

58

58

pharmaphorum

OCTOBER 19, 2022

Due to the combined impact of emerging technologies, changing provider preferences, and an evolving post-pandemic world, pharma must navigate new ways to engage providers with relevant, science-driven, digital content. The post Every scientific message has a story. Medical communications must adapt to effectively bring these to life.

Communication 98

Communication 98

pharmaphorum

FEBRUARY 1, 2022

Leveraging pandemic insights and digital progress. In parallel, the pandemic accelerated digital advances that were already underway. • Read the full article in pharmaphorum’s Deep Dive digital magazine. The pandemic forced trial innovation across the board. “It

52

52

Pharma Marketing Network

JULY 17, 2023

Ritesh bills himself as a digital and social evangelist, and he has been evangelizing digital since the early days of the dot com boom in the late 1990’s. He joined Ogilvy in 2014, as the Chief Digital Officer for Ogilvy CommonHealth, the specialist health care agency within the Ogilvy Group.

52

52

pharmaphorum

DECEMBER 16, 2020

Experts from Healthware Group explore how companies can rebuild their approach to digital from the ground up for the benefit of patients. Digital is not just a nice-to-have for pharma companies – it’s a necessity for ensuring that patients have the best possible outcomes in modern healthcare systems.

Communication 58

Communication 58

pharmaphorum

OCTOBER 5, 2020

Modern day recognisable simulations have been used in medical education since the 18th century and have evolved into realistic and medically accurate physical and digital solutions designed to allow learners to simulate a scenario-based encounter with a patient in a safe environment.

Communication 71

Communication 71

pharmaphorum

JANUARY 4, 2023

The accelerated adoption of digital channels – combined with the ongoing disruption caused by COVID-19 – has changed the way that customers seek out and engage with content. “We As such, demand for greater volumes of personalised digital content has skyrocketed. We have changed as consumers,” explains Viseven CEO Nataliya Andreychuk.

Communication 52

Communication 52

pharmaphorum

FEBRUARY 17, 2022

Unfortunately, this has created a deep divide between what patients need from new treatments and the products companies develop and market to them. As Duman puts it, “trying to change healthcare’s focus from what is the matter with you, to what matters to you”. • Read the full article in pharmaphorum’s Deep Dive digital magazine.

52

52

pharmaphorum

NOVEMBER 10, 2020

Digital therapeutics are gaining momentum worldwide and offer developers, including pharma, both a huge opportunity and a stimulating market access challenge, say Olaf Schoeman and Emanuele Arcà. Germany is spearheading these advances, particularly with its 2019 changes on national digital health reimbursement.

Pharmaceutical Companies 72

Pharmaceutical Companies Pharmaceutical Companies 72

pharmaphorum

APRIL 19, 2022

However, as the industry moves to occupy more virtual spaces, a new breed of industry influencers has emerged – digital opinion leaders (DOLs). You will learn: What is a digital opinion leader? How to identify digital opinion leaders. How to engage digital opinion leaders. How to use digital opinion leaders.

98

98

pharmaphorum

JULY 23, 2021

As the field becomes more crowded, digital tools may be critical for improving outcomes, says a new whitepaper. It says that the growth in treatment options is making it more difficult for oncologists to match patients to the right therapy – but there are many ways in which digital tools can help address this by leveraging data.

52

52

pharmaphorum

DECEMBER 14, 2022

Yet, until relatively recently, capturing and collecting this data was challenging for HCPs and drugmakers. • Read the full article in pharmaphorum’s Deep Dive digital magazine. In fact, there is a wealth of knowledge to be found in the day-to-day experiences of cancer patients.

52

52

pharmaphorum

FEBRUARY 10, 2022

Digital health is transforming the way that we approach healthcare, but how can companies make the most of this new multi-channel engagement model? What followed was a flurry of activity in the digital space. The post Powered by digital: driving transformation and innovation in healthcare appeared first on.

Communication 52

Communication 52

pharmaphorum

OCTOBER 4, 2021

M3’s Tim Russell and Maxim Polyakov, together with Digital Futureway’s Heather Hancock, discuss new research on how doctor engagement has been altered by COVID-19. COVID-19 forced an unprecedented shift towards the virtual delivery of healthcare, suddenly compelling doctors increasingly to use digital means to care for their patients.

Communication 71

Communication 71

pharmaphorum

MAY 21, 2021

This article appears in our digital magazine Deep Dive: Market Access 2021. Read below for a preview: What are some of the challenges of developing innovative therapies for ultra-rare patient populations? There are challenges at every stage of the journey from lab to patient.

118

118

pharmaphorum

OCTOBER 14, 2020

Mike Dixon, CEO of the Healthcare Communications Association, discusses the biggest challenges facing the sector during and after COVID, from digital innovation to talent and sustainability. The post The right people and the right environment for innovative comms appeared first on.

Communication 52

Communication 52

pharmaphorum

DECEMBER 19, 2022

HCPs use a wide variety of digital channels to connect with the medical community. Research Partnership refers to these HCP social media influencers as Key Online Influencers (KOIs). • Read the full article in pharmaphorum’s Deep Dive digital magazine. Physician influencers.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

pharmaphorum

OCTOBER 2, 2020

Ian Daley and Jonathan Macdonald from EPG Health tell us how pharma can take cues from digital publishing and companies like Amazon to make sure their messages get heard. Even before COVID-19, physicians were becoming more and more digitally savvy, especially as millennials entered the workforce.

Communication 63

Communication 63

pharmaphorum

OCTOBER 12, 2020

Experts from ICON tell us how they have found success in using enhanced media fit for the digital age. Meanwhile, 26% of physicians indicated that in the future they would not have time for print at all. • Read the full article in pharmaphorum’s Deep Dive digital magazine.

Communication 52

Communication 52

pharmaphorum

JUNE 3, 2021

This article appears in our digital magazine Deep Dive: Market Access 2021. That’s not all that new, but perhaps the change in emphasis is welcome. • Read the full article in pharmaphorum’s Deep Dive digital magazine. Leela Barham takes stock. The post Time for a NICE change appeared first on.

Documentation 98

Documentation 98